Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/23/2012CA2827509A1 Methods for treating diseases of the retina
08/23/2012CA2827488A1 Methods for controlling pain in equines using a transdermal solution of fentanyl
08/23/2012CA2827470A1 Transdermal delivery system containing galantamine or salts thereof
08/23/2012CA2827435A1 Methods for controlling pain in canines using a transdermal solution of fentanyl
08/23/2012CA2827398A1 Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
08/23/2012CA2827383A1 Molecular switch for neuronal outgrowth
08/23/2012CA2827373A1 Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea
08/23/2012CA2827311A1 Chroman-spirocyclic piperidine amides as modulators of ion channels
08/23/2012CA2827299A1 Liquid propellant-free formulation comprising an antimuscarinic drug
08/23/2012CA2827289A1 Absorbent dressings with painkilling activity
08/23/2012CA2827282A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/23/2012CA2827261A1 6-cyclobutyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
08/23/2012CA2827172A1 Selective fak inhibitors
08/23/2012CA2827171A1 Fak inhibitors
08/23/2012CA2827118A1 Compositions and methods for delivering nucleic acid to a cell
08/23/2012CA2827045A1 Pharmaceutical composition
08/23/2012CA2826648A1 Aminoindane compounds and use thereof in treating pain
08/23/2012CA2826646A1 Compositions comprising peroxy a-ketocarboxylic acid and methods for producing and using the same
08/23/2012CA2826463A1 Novel sulfonaminoquinoline hepcidin antagonists
08/23/2012CA2826277A1 Sorafenib derivatives as seh inhibitors
08/23/2012CA2826154A1 Peripherially acting .mu. opioid antagonists
08/23/2012CA2826074A1 Pharmaceutical formulation for topical administration comprising b220
08/23/2012CA2825991A1 Extended release powder and aqueous suspension comprising methylphenidate
08/23/2012CA2825917A1 Filmcoated solid dosage forms comprising honey in the coating
08/23/2012CA2825737A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/23/2012CA2825594A1 Water soluble nutritional compositions comprising cereal beta-glucan and resistant starch
08/23/2012CA2823988A1 Novel benzodioxole piperazine compounds
08/23/2012CA2823877A1 Novel pyrazole and imidazole derivatives useful as orexin antagonists
08/23/2012CA2822534A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
08/23/2012CA2810334A1 Methods and compositions relating to coagulation assays
08/23/2012CA2732440A1 Cystamine analogues for the treatment of parkinson`s disease
08/22/2012EP2490026A1 Marker associated with non-alcoholic steatohepatitis
08/22/2012EP2490021A1 Modulators of PRR and GPCR signalling
08/22/2012EP2489735A1 Aptamer capable of binding to viral hemorrhagic septicemia virus
08/22/2012EP2489729A2 Apoptotic cell-mediated transfection of mammalian cells with interfering RNA
08/22/2012EP2489669A1 Haprolid and derivatives thereof as inhibitors of HCV
08/22/2012EP2489667A1 Quinoxaline derivative
08/22/2012EP2489666A2 Chemically and chirally pure solifenacin base and its salts
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2489661A1 Impurity of lapatinib and salts thereof
08/22/2012EP2489659A1 Modulators of ATP-binding cassette transporters
08/22/2012EP2489658A1 3-Heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
08/22/2012EP2489657A2 Inhibitors of histone deacetylase
08/22/2012EP2489656A1 Selective androgen receptor modulators (sarms) and uses thereof
08/22/2012EP2489654A1 Cyclohexane compounds and their use as antibiotics
08/22/2012EP2489653A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/22/2012EP2489652A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/22/2012EP2489408A1 Amino acid compound and use of same for treating intrauterine growth restriction (IUGR) and for parenteral feeding of extremely premature infants
08/22/2012EP2489370A1 Use of a synergistic compound as a therapeutic agent or disinfectant
08/22/2012EP2489367A1 Lyophilised antigen composition
08/22/2012EP2489357A1 Novel Triclosan Salts
08/22/2012EP2489356A1 Novel Triclosan Salts
08/22/2012EP2489355A1 Wound-healing composition
08/22/2012EP2489354A1 Pharmaceutical formulation of B220 for topical treatment of herpes
08/22/2012EP2489353A1 Sofinicline (ABT-894) for attention-deficit/hyperactivity disorder
08/22/2012EP2489352A1 Medicaments for inhibiting thrombosis
08/22/2012EP2489351A1 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treament of cancer thereof
08/22/2012EP2489350A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
08/22/2012EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
08/22/2012EP2489347A1 Process for the production of injectable preparations of phloroglucinol and the injectable preparations so obtained
08/22/2012EP2488646A1 Compositions for controlling varroa mites in bees
08/22/2012EP2488645A1 Exon skipping therapy for dysferlinopathies
08/22/2012EP2488642A1 Compositions and methods for the treatment of drug-induced hand-foot syndrome
08/22/2012EP2488640A1 Antiproliferative agent
08/22/2012EP2488537A1 Silyl polymeric benzoic acid ester compounds, uses, and compositions thereof
08/22/2012EP2488534A1 Metal complexes of n-heterocyclic carbenes
08/22/2012EP2488533A1 Imidazothiazole-chalcone derivatives as potential anticancer agents and process for the preparation thereof
08/22/2012EP2488532A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488530A1 Spirocyclic piperidine derivatives useful as renin inhibitors
08/22/2012EP2488529A2 Spirocyclic derivatives as histone deacetylase inhibitors
08/22/2012EP2488528A1 Pyrrolo [3,2 -e][1,2,4]triazolo [1,5-a]pyrimidines derivatives as inhibitors of microglia activation
08/22/2012EP2488527A1 Pyrrolo [3, 2 -e][1,2,4]triazolo [1,5 -a]pyrimidines derivatives as inhibitors of microglia activation
08/22/2012EP2488526A1 Compounds for the treatment of hepatitis c
08/22/2012EP2488525A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488524A1 Pyrrolo[2,3-d]pyrimidine compounds
08/22/2012EP2488523A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
08/22/2012EP2488522A2 Novel method for preparing entecavir and intermediate used therein
08/22/2012EP2488521A1 Macrocyclic integrase inhibitors
08/22/2012EP2488520A1 Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor
08/22/2012EP2488519A1 Pyrazolopyridine derivatives as anticancer agent
08/22/2012EP2488517A1 Hiv integrase inhibitors
08/22/2012EP2488514A1 Indole and azaindole modulators of the alpha 7 nachr
08/22/2012EP2488513A2 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
08/22/2012EP2488512A1 Cgrp receptor antagonists
08/22/2012EP2488511A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase
08/22/2012EP2488508A1 Process for the preparation of f-series prostaglandins
08/22/2012EP2488504A1 Sulfoxide derivatives for treating tumors
08/22/2012EP2488503A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
08/22/2012EP2488502A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488500A1 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
08/22/2012EP2488493A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
08/22/2012EP2488491A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
08/22/2012EP2488489A2 C-linked hydroxamic acid derivatives useful as antibacterial agents
08/22/2012EP2488486A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
08/22/2012EP2488210A2 Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
08/22/2012EP2488192A1 Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor
08/22/2012EP2488186A1 Anti-neoplastic uses of artemin antagonists
08/22/2012EP2488184A1 Combination
08/22/2012EP2488183A2 Composition for inhibiting tgf- comprising imidazopurine derivatives
08/22/2012EP2488182A1 Treating neurotoxicity associated with combinations of 5 - fu or its prodrugs and dpd inhibitors
1 ... 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 ... 7860